US Stock MarketDetailed Quotes

VOR Vor Biopharma

Watchlist
  • 0.791
  • -0.009-1.07%
Close Nov 27 16:00 ET
  • 0.810
  • +0.019+2.35%
Post 20:01 ET
54.35MMarket Cap-482P/E (TTM)

Vor Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.26%28.51M
-9.76%29.04M
6.26%32.33M
34.92%126.04M
13.75%28.12M
46.53%35.32M
47.64%32.17M
33.43%30.42M
35.35%93.42M
35.07%24.73M
Selling and administrative expenses
-13.15%6.7M
-12.87%7.21M
-5.91%8M
9.88%31.72M
-5.69%7.23M
6.70%7.71M
28.15%8.28M
13.13%8.51M
34.34%28.87M
36.52%7.66M
-General and administrative expense
-13.15%6.7M
-12.87%7.21M
-5.91%8M
9.88%31.72M
-5.69%7.23M
6.70%7.71M
28.15%8.28M
13.13%8.51M
34.34%28.87M
36.52%7.66M
Research and development costs
-20.97%21.82M
-8.68%21.82M
10.98%24.32M
46.11%94.32M
22.48%20.9M
63.59%27.61M
55.85%23.9M
43.42%21.92M
35.81%64.55M
34.42%17.06M
Operating profit
19.26%-28.51M
9.76%-29.04M
-6.26%-32.33M
-34.92%-126.04M
-13.75%-28.12M
-46.53%-35.32M
-47.64%-32.17M
-33.43%-30.42M
-35.35%-93.42M
-35.07%-24.73M
Net non-operating interest income expense
-55.13%954K
-45.51%1.2M
-23.48%1.52M
517.30%8.17M
128.59%1.86M
579.23%2.13M
1,550.38%2.2M
3,057.14%1.99M
1,012.61%1.32M
1,409.26%815K
Non-operating interest income
-55.13%954K
-45.51%1.2M
-23.48%1.52M
517.30%8.17M
128.59%1.86M
579.23%2.13M
1,550.38%2.2M
3,057.14%1.99M
1,012.61%1.32M
1,409.26%815K
Other net income (expense)
Income before tax
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
Income tax
Net income
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
Net income continuous Operations
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
Minority interest income
Net income attributable to the parent company
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-33.67%-92.09M
-31.00%-23.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.97%-27.56M
7.14%-27.84M
-8.34%-30.8M
-27.98%-117.86M
-9.83%-26.26M
-39.52%-33.19M
-38.41%-29.98M
-25.05%-28.43M
-31.32%-92.09M
-31.00%-23.91M
Basic earnings per share
18.37%-0.4
8.89%-0.41
-4.65%-0.45
24.89%-1.75
26.92%-0.38
22.22%-0.49
22.41%-0.45
29.51%-0.43
-10.95%-2.33
-8.33%-0.52
Diluted earnings per share
18.37%-0.4
8.89%-0.41
-4.65%-0.45
24.89%-1.75
26.92%-0.38
22.22%-0.49
22.41%-0.45
29.51%-0.43
-10.95%-2.33
-8.33%-0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.26%28.51M-9.76%29.04M6.26%32.33M34.92%126.04M13.75%28.12M46.53%35.32M47.64%32.17M33.43%30.42M35.35%93.42M35.07%24.73M
Selling and administrative expenses -13.15%6.7M-12.87%7.21M-5.91%8M9.88%31.72M-5.69%7.23M6.70%7.71M28.15%8.28M13.13%8.51M34.34%28.87M36.52%7.66M
-General and administrative expense -13.15%6.7M-12.87%7.21M-5.91%8M9.88%31.72M-5.69%7.23M6.70%7.71M28.15%8.28M13.13%8.51M34.34%28.87M36.52%7.66M
Research and development costs -20.97%21.82M-8.68%21.82M10.98%24.32M46.11%94.32M22.48%20.9M63.59%27.61M55.85%23.9M43.42%21.92M35.81%64.55M34.42%17.06M
Operating profit 19.26%-28.51M9.76%-29.04M-6.26%-32.33M-34.92%-126.04M-13.75%-28.12M-46.53%-35.32M-47.64%-32.17M-33.43%-30.42M-35.35%-93.42M-35.07%-24.73M
Net non-operating interest income expense -55.13%954K-45.51%1.2M-23.48%1.52M517.30%8.17M128.59%1.86M579.23%2.13M1,550.38%2.2M3,057.14%1.99M1,012.61%1.32M1,409.26%815K
Non-operating interest income -55.13%954K-45.51%1.2M-23.48%1.52M517.30%8.17M128.59%1.86M579.23%2.13M1,550.38%2.2M3,057.14%1.99M1,012.61%1.32M1,409.26%815K
Other net income (expense)
Income before tax 16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M
Income tax
Net income 16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M
Net income continuous Operations 16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M
Minority interest income
Net income attributable to the parent company 16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-33.67%-92.09M-31.00%-23.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.97%-27.56M7.14%-27.84M-8.34%-30.8M-27.98%-117.86M-9.83%-26.26M-39.52%-33.19M-38.41%-29.98M-25.05%-28.43M-31.32%-92.09M-31.00%-23.91M
Basic earnings per share 18.37%-0.48.89%-0.41-4.65%-0.4524.89%-1.7526.92%-0.3822.22%-0.4922.41%-0.4529.51%-0.43-10.95%-2.33-8.33%-0.52
Diluted earnings per share 18.37%-0.48.89%-0.41-4.65%-0.4524.89%-1.7526.92%-0.3822.22%-0.4922.41%-0.4529.51%-0.43-10.95%-2.33-8.33%-0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data